Van ECK Associates Corp Buys 225,814 Shares of Trinity Capital Inc. $TRIN

Van ECK Associates Corp raised its stake in Trinity Capital Inc. (NASDAQ:TRIN) by 14.9% during the 3rd quarter, Holdings Channel reports. The fund owned 1,746,217 shares of the company’s stock after acquiring an additional 225,814 shares during the period. Van ECK Associates Corp’s holdings in Trinity Capital were worth $27,032,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the stock. SMH Capital Advisors Inc. boosted its holdings in shares of Trinity Capital by 2.6% during the third quarter. SMH Capital Advisors Inc. now owns 138,961 shares of the company’s stock worth $2,097,000 after acquiring an additional 3,476 shares during the period. Private Advisor Group LLC grew its position in shares of Trinity Capital by 7.8% in the third quarter. Private Advisor Group LLC now owns 28,549 shares of the company’s stock valued at $442,000 after purchasing an additional 2,071 shares during the last quarter. Prevail Innovative Wealth Advisors LLC bought a new position in shares of Trinity Capital during the third quarter worth approximately $1,959,000. Melia Wealth LLC lifted its holdings in Trinity Capital by 2.6% during the 3rd quarter. Melia Wealth LLC now owns 1,179,296 shares of the company’s stock worth $18,256,000 after purchasing an additional 30,360 shares during the last quarter. Finally, Denali Advisors LLC lifted its holdings in Trinity Capital by 2.9% during the 3rd quarter. Denali Advisors LLC now owns 105,472 shares of the company’s stock worth $1,633,000 after purchasing an additional 2,942 shares during the last quarter. 24.62% of the stock is currently owned by institutional investors and hedge funds.

Trinity Capital Price Performance

Trinity Capital stock opened at $14.80 on Thursday. The firm has a market cap of $1.23 billion, a PE ratio of 7.55 and a beta of 0.55. The stock’s fifty day moving average price is $15.71 and its two-hundred day moving average price is $15.41. Trinity Capital Inc. has a one year low of $12.50 and a one year high of $17.20.

Trinity Capital (NASDAQ:TRIN) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.01. The business had revenue of $58.89 million during the quarter, compared to the consensus estimate of $79.83 million. Trinity Capital had a return on equity of 14.97% and a net margin of 46.18%. Sell-side analysts expect that Trinity Capital Inc. will post 2.06 earnings per share for the current fiscal year.

Trinity Capital Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be issued a dividend of $0.17 per share. This represents a c) dividend on an annualized basis and a dividend yield of 13.8%. The ex-dividend date of this dividend is Friday, March 13th. Trinity Capital’s dividend payout ratio is 104.08%.

Insider Activity

In other news, CEO Kyle Steven Brown purchased 3,333 shares of Trinity Capital stock in a transaction that occurred on Monday, March 2nd. The shares were acquired at an average price of $14.90 per share, for a total transaction of $49,661.70. Following the transaction, the chief executive officer owned 376,775 shares of the company’s stock, valued at approximately $5,613,947.50. The trade was a 0.89% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. In the last quarter, insiders have purchased 7,741 shares of company stock worth $115,358. Company insiders own 5.31% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on TRIN shares. Citizens Jmp set a $17.50 price objective on Trinity Capital in a report on Monday, December 8th. Loop Capital set a $17.00 target price on shares of Trinity Capital in a research report on Thursday, December 11th. Capital One Financial set a $17.00 price target on shares of Trinity Capital in a research note on Thursday, December 11th. Clear Str raised shares of Trinity Capital to a “strong-buy” rating in a research report on Wednesday, February 4th. Finally, Citigroup reiterated an “outperform” rating on shares of Trinity Capital in a research note on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $16.29.

Key Headlines Impacting Trinity Capital

Here are the key news stories impacting Trinity Capital this week:

• Positive Sentiment: Trinity committed $35 million in growth capital to Neuros Medical, expanding its MedTech portfolio and potential interest/fee income as Neuros scales adoption of its FDA‑approved therapy. Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption
• Positive Sentiment: Trinity provided $20 million to Emboline to support commercialization of the Emboliner embolic protection system — another MedTech deployment that should grow Trinity’s asset base and future yield. Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology
• Positive Sentiment: Insiders increased holdings: Chairman Steve L. Brown and Director Ronald E. Estes purchased shares in recent filings, a common signal of management confidence in the company’s outlook. SEC Ownership Filing
• Neutral Sentiment: An analysis contrasting Trinity with Chicago Atlantic BDC provides comparative context for investors evaluating BDC positioning and valuation, but contains no company-specific catalysts. Contrasting Chicago Atlantic BDC (NASDAQ:LIEN) and Trinity Capital (NASDAQ:TRIN)
• Negative Sentiment: A Seeking Alpha piece highlights a rating downgrade on TRINZ 7.875% Notes due 2029 and expects those notes may be called as Trinity pivots to cheaper secured funding — this raises short‑term refinancing and credit‑cost concerns for some investors. TRINZ: To Refi Or Not To Refi (Rating Downgrade)

Trinity Capital Profile

Trinity Capital Corporation (NASDAQ: TRIN) is a publicly traded business development company that provides flexible financing solutions to venture-backed and growth-stage companies. As a venture lender, Trinity Capital offers customized capital structures, including secured debt and equity co-investment, designed to support companies that have progressed beyond early-stage funding but still require non-dilutive growth capital.

The company focuses its investments on technology-driven sectors such as software, fintech, healthcare, life sciences and cleantech.